Online citations, reference lists, and bibliographies.
← Back to Search

PH-responsive Polymer-liposomes For Intracellular Drug Delivery And Tumor Extracellular Matrix Switched-on Targeted Cancer Therapy.

Yi-Ting Chiang, Chun-Liang Lo
Published 2014 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
This study presents a tumor-extracellular matrix pH-induced targeting liposome (ECM-targeting liposomes), crosslinked from methoxy-poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide-co-histidine)-cholesterol copolymers and biotin2-polyethylene glycol crosslinkers by hydrogen bonds to overcome the defects of liposomes. In this study, ECM-targeting liposomes were completely investigated their pH-responsibility, drug releasing behaviors, anticancer efficiencies and the time-dependent organ distribution and toxic effects. Experimental results indicate that ECM-targeting liposomes showed rapid drug releasing profiles in acidic conditions. Because the ECM-targeting liposomes accumulated preferentially in tumor, the ECM-targeting liposomes exhibited exceptional anticancer activity in vivo and lower hepatic and renal toxicity. The ECM-targeting liposomes which are switched on the targeting ability in tumor ECM possess potential for future application in anticancer therapy.
This paper references
10.1016/0731-7085(95)01301-Z
A sensitive procedure for the quantitation of free and N-(2-hydroxypropyl) methacrylamide polymer-bound doxorubicin (PK1) and some of its metabolites, 13-dihydrodoxorubicin, 13-dihydrodoxorubicinone and doxorubicinone, in human plasma and urine by reversed-phase HPLC with fluorimetric detection.
D. Fraier (1995)
10.1021/NL0479987
Super pH-sensitive multifunctional polymeric micelle.
E. Lee (2005)
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
S. Huang (1992)
10.1016/S0169-409X(97)00128-2
Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo.
Cullis (1998)
10.1038/11710
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity
Gitanjali Adlakha-Hutcheon (1999)
10.1126/SCIENCE.1095833
Drug Delivery Systems: Entering the Mainstream
T. Allen (2004)
10.1016/j.biomaterials.2010.11.051
Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery.
Pei-Lin Lu (2011)
10.1016/S0169-409X(99)00042-3
Possibility of active targeting to tumor tissues with liposomes.
Maruyama (1999)
10.1021/MA00139A009
pH-Dependent complexation of poly(acrylic acid) derivatives with phospholipid vesicle membranes
K. Seki (1984)
10.1016/S0168-3659(96)01501-5
Toxicity of doxorubicin entrapped within long-circulating liposomes
T. Daemen (1997)
10.1016/S0169-409X(99)00043-5
Immunoliposomes for the targeted delivery of antitumor drugs.
Mastrobattista (1999)
10.1021/bc7004736
Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH.
Naoki Sakaguchi (2008)
10.1016/S0005-2736(99)00234-5
In vitro characterization of a novel polymeric-based pH-sensitive liposome system.
M. Zignani (2000)
10.1126/SCIENCE.7434025
pH-sensitive liposomes: possible clinical implications.
M. Yatvin (1980)
10.2165/00003088-200342050-00002
Pharmacokinetics of Pegylated Liposomal Doxorubicin
A. Gabizon (2003)
10.1016/J.ADDR.2004.01.011
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
A. Gabizon (2004)
10.1021/CM402614K
Polymer–Liposome Complexes with a Functional Hydrogen-Bond Cross-Linker for Preventing Protein Adsorption and Improving Tumor Accumulation
Yi-Ting Chiang (2013)
10.1002/(SICI)1099-1352(199634/12)9:5/6<335::AID-JMR309>3.0.CO;2-0
Affinity liposomes in vivo: factors influencing target accumulation
V. Torchilin (1996)
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
A. Gabizon (2003)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1016/j.biomaterials.2013.02.028
Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
Y. Lin (2013)
10.1006/JCIS.1996.4608
Characterization of pH-Dependent Poly(acrylic Acid) Complexation with Phospholipid Vesicles
Fujiwara (1997)
10.1073/PNAS.88.24.11460
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
D. Papahadjopoulos (1991)
On the characterization of pHsensitive liposome/polymer complexes. Biomacromolecules 2003;4:240e8
E Roux (2003)
10.1016/0014-5793(96)00521-2
Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface‐grafted poly(ethylene glycol)
D. Kirpotin (1996)
10.1016/0005-2736(93)90105-9
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
G. Haran (1993)
Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
D. Drummond (1999)
10.1021/BM025651X
On the characterization of pH-sensitive liposome/polymer complexes.
Emmanuelle Roux (2003)
10.1002/IJC.2910610520
Liposomal doxorubicin‐induced toxicity: Depletion and impairment of phagocytic activity of liver macrophages
T. Daemen (1995)
10.1016/0005-2736(94)90325-5
Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups.
K. Kono (1994)
10.1016/j.jconrel.2008.05.003
Recent progress in tumor pH targeting nanotechnology.
E. Lee (2008)
10.1016/S0305-7372(02)80004-4
Pegylation: engineering improved pharmaceuticals for enhanced therapy.
G. Molineux (2002)
10.1016/J.JINORGBIO.2004.07.009
Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours.
G. Russell-Jones (2004)
10.1002/1097-0142(19950415)75:8<2169::AID-CNCR2820750822>3.0.CO;2-H
Hand‐foot syndrome associated with liposome‐encapsulated doxorubicin therapy
K. Gordon (1995)
10.1021/JA070748I
Polymer-caged lipsomes: a pH-responsive delivery system with high stability.
S. Lee (2007)



This paper is referenced by
10.1016/J.NANTOD.2014.10.001
Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
Heleen Dewitte (2014)
10.1016/B978-0-12-409547-2.12540-5
Targeting and Triggered Release Using Lipid-Based Supramolecular Assemblies as Medicinal Nanocarriers
S. Alam (2017)
10.1002/chem.201700060
Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
X. Wang (2017)
10.1016/B978-0-323-52725-5.00009-5
Application Potential of Engineered Liposomes in Tumor Targeting
Ankit Jain (2017)
10.1039/C5TB02083B
Smart polymeric particle encapsulated gadolinium oxide and europium: theranostic probes for magnetic resonance/optical imaging and antitumor drug delivery.
Ruiqing Liu (2016)
10.1016/j.canlet.2016.01.050
Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
Keunsoo Jeong (2016)
10.1016/B978-0-323-42866-8.00008-3
Natural and synthetic polymers for drug delivery and targeting
G. D. Mogosanu (2016)
10.4155/tde-2018-0062
Nanomedicines for cancer therapy: current status, challenges and future prospects.
Gizem Bor (2019)
10.1016/J.EURPOLYMJ.2017.04.019
NIR-laser switched ICG/DOX loaded thermo-responsive polymeric capsule for chemo-photothermal targeted therapy
A. Li (2017)
10.1016/j.colsurfb.2016.02.025
Synthesis and evaluation of cholesterol-grafted PEGylated peptides with pH-triggered property as novel drug carriers for cancer chemotherapy.
C. Zhang (2016)
10.1016/j.biomaterials.2016.01.061
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.
Manju Kanamala (2016)
10.1039/C4PY01750A
Dual-stimuli sensitive keratin graft PHPMA as physiological trigger responsive drug carriers
Qinmei Li (2015)
Self Regulatory Drug Transport: An Intelligent Drug Delivery System
A. Jain (2018)
10.1016/j.jconrel.2015.05.127
pH-triggered drug carrier for targeted co-delivery of genes and drugs.
Min Wang (2015)
10.1016/j.colsurfb.2015.03.046
RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Minglu Chang (2015)
10.1002/wnan.1450
Stimuli-responsive liposomes for drug delivery.
Y. Lee (2017)
10.3390/md17090485
Inhibition Effect of Triglyceride Accumulation by Large Yellow Croaker Roe DHA-PC in HepG2 Cells
Xiaodan Lu (2019)
10.1007/s10965-019-1987-y
Physico-chemical based mechanistic insight into surfactant modulated sodium Carboxymethylcellulose film for skin tissue regeneration applications
Muhammad Ali (2019)
10.1039/C5RA16199A
Paramagnetic, pH and temperature-sensitive polymeric particles for anticancer drug delivery and brain tumor magnetic resonance imaging
Ruiqing Liu (2015)
Liposomy jako nośniki substancji aktywnych przenoszonych w głąb skóry
U. Goik (2015)
10.1016/j.biomaterials.2014.11.010
Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior.
Y. Li (2015)
10.1016/B978-0-323-37127-8.00012-1
4.4 – Theranostics
R. S. Kalash (2016)
10.1002/jps.24291
Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
H. Fu (2015)
10.1007/S12209-016-2710-2
Layered double hydroxide modified by PEGylated hyaluronic acid as a hybrid nanocarrier for targeted drug delivery
A. Dong (2016)
10.7150/thno.14858
The Smart Drug Delivery System and Its Clinical Potential
Dong Liu (2016)
10.1016/j.ijpharm.2016.07.060
Tumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiency.
Wei-liang Chen (2016)
10.1007/s00249-015-1055-4
Inducible release of particulates from liposomes using the mechanosensitive channel of large conductance and l-α-lysophosphatidylcholine
Alexander Foo (2015)
10.1021/acsami.5b08202
Aggregation-Induced-Emissive Molecule Incorporated into Polymeric Nanoparticulate as FRET Donor for Observing Doxorubicin Delivery.
Xiongqi Han (2015)
10.7150/thno.13896
A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer
Z. Dan (2016)
10.1515/ntrev-2016-0102
Nanomaterials for cancer therapies
Qing Zhou (2017)
10.1021/acsami.5b05984
Biodegradation and Toxicity of Protease/Redox/pH Stimuli-Responsive PEGlated PMAA Nanohydrogels for Targeting Drug delivery.
Sha Jin (2015)
10.1002/smll.201903296
pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific Therapy.
V. Juang (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar